Talis biomedical investor
Web15 Mar 2024 · MENLO PARK, Calif. - March 15, 2024 - Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today provided a business update and reported financial results for the fourth quarter and … WebAbout Talis Biomedical Talis is dedicated to transforming diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, low cost, and rapid molecular testing for infectious diseases at the point-of-care. The company is developing the Talis One, a compact, sample-to-answer, cloud-enabled ...
Talis biomedical investor
Did you know?
Web30 Sep 2024 · REDWOOD CITY, Calif., Nov. 03, 2024 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity …
Web30 Sep 2024 · Talis is dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care. … Web12 Feb 2024 · Investors of Talis Biomedical include National Institutes of Health, National Institute of Allergy and Infectious Diseases and CARB-X. Discover the right solution for your team The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology …
WebTalis Biomedical is developing a point-of-care, sample-to-answer platform. Menlo Park, California, United States 51-100 Grant Public talisbio.com 29,786 Highlights Stock Symbol NASDAQ:TLIS Total Funding Amount $8.6M Contacts 74 Employee Profiles 8 Investors 1 Similar Companies 4 Find More Contacts for Talis Biomedical Rob Kelley CEO WebTalis Biomedical Corporation; Chief Executive Officer Brian Coe; Chief Financial Officer J. Roger Moody, Jr. Director Felix Baker; Director Raymond Cheong; Director Melissa Gilliam; …
WebPresently, Jill Green is Senior Vice President-Legal at Talis Biomedical Corp.
WebHeadquarters Regions San Francisco Bay Area, Silicon Valley, West Coast. Founded Date 2010. Founders Brian Coe, Rustem Ismagilov. Operating Status Active. Last Funding Type … luxxe white vs ishigakiWebMENLO PARK, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests … luxx forged wheelsWebTalis One’s easy-to-use, sample-to-answer workflow enables infectious disease testing by healthcare professionals in a variety of point-of-care settings. The single-use test cartridge is a critical part of the system and where all the LAMP reactions take place. One of the key advantages of our testing workflow is the inclusion of a solid ... kings county nova scotia court reportWeb20 Jan 2024 · The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2024 alone the firm secured over $438 … luxxe white philippinesWeb23 Mar 2024 · Investing.com - Talis Biomedical (NASDAQ: TLIS) reported first quarter EPS of $-1.010, $0.33 worse than the analyst estimate of $-0.684. Revenue for the quarter came in at $250K versus the consensus estimate of $780K. Talis Biomedical's stock price closed at $0.540. It is up 12.500% in the last 3 months and down -64.730% in the last 12 months. luxx gline threadsWeb11 Apr 2024 · Talis Biomedical. $4.81 million. 2.58. -$113.01 million. ($4.24) -0.11. Seer has higher revenue and earnings than Talis Biomedical. Seer is trading at a lower price-to-earnings ratio than Talis ... kings county nova scotia mapWeb11 Apr 2024 · 47.1% of Talis Biomedical shares are held by institutional investors. Comparatively, 76.2% of Seer shares are held by institutional investors. 42.0% of Talis Biomedical shares are held by insiders. luxxe white soap and capsule montalban rizal